Cutter Capital Management »

Eli Lilly & Co. shares owned by Cutter Capital Management

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Cutter Capital Management from 13F filings

Historical chart of Cutter Capital Management investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Cutter Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Cutter Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $15M 17k 885.94
2024-03-31 $8.6M 11k 777.96

More positions owned by Cutter Capital Management

Gilead Sciences (GILD)
Bristol Myers Squibb (BMY)
Royalty Pharma Shs Class A (RPRX)
Agilent Technologies Inc C ommon (A)
Ultragenyx Pharmaceutical (RARE)
Legend Biotech Corp Sponsored Ads (LEGN)
Insmed Com Par $.01 (INSM)
Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Harmony Biosciences Hldgs In (HRMY)
Perrigo SHS (PRGO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Springworks Therapeutics (SWTX)
Miragen Therapeutics (VRDN)
Sarepta Therapeutics (SRPT)

View all positions for Cutter Capital Management

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co
PRIMECAP Management Company
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
International Assets Investment Management
Bank of America Corporation
Jennison Associates
Bank of New York Mellon

View all funds holding Eli Lilly & Co.